Find Doxylamine Succinate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

396RELATED EXCIPIENT COMPANIES

665EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

GLOBAL SALES INFORMATION

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 562-10-7, Decapryn, Doxylamine (succinate), Gittalun, Unisom, Doxylamine hydrogen succinate
Molecular Formula
C21H28N2O5
Molecular Weight
388.5  g/mol
InChI Key
KBAUFVUYFNWQFM-UHFFFAOYSA-N
FDA UNII
V9BI9B5YI2

Doxylamine Succinate
Doxylamine Succinate is a pyridine derivate histamine H1 antagonist with pronounced sedative properties. Doxylamine succinate competitively blocks the histamine H1 receptor and limits the typical allergic and anaphylactic responses, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contraction of gastrointestinal smooth muscle, caused by actions of histamine on bronchial and gastrointestinal smooth muscles, and on capillaries. This drug also prevents histamine-induced pain and itching of the skin and mucous membranes.
1 2D Structure

Doxylamine Succinate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
2.1.2 InChI
InChI=1S/C17H22N2O.C4H6O4/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16;5-3(6)1-2-4(7)8/h4-12H,13-14H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
2.1.3 InChI Key
KBAUFVUYFNWQFM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
V9BI9B5YI2
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 562-10-7

2. Decapryn

3. Doxylamine (succinate)

4. Gittalun

5. Unisom

6. Doxylamine Hydrogen Succinate

7. Doxylamine Succinate Salt

8. Hoggar N

9. Doxy-sleep-aid

10. Evigoa D

11. A-h Injection

12. Decapryn Succinate

13. Doxylamine Succinate (1:1)

14. Alsadorm

15. Mereprine

16. Decapryn Succinate (1:1)

17. Alsodorm

18. Donormil

19. Donormyl

20. Dormidina

21. Meraprina

22. Nsc-74772

23. Doxylamine Succinate [usp]

24. V9bi9b5yi2

25. Butanedioic Acid;n,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine

26. Mls000028417

27. 2-dimethylaminoethoxyphenylmethyl-2-picoline Succinate (1:1)

28. Chebi:82461

29. N,n-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine Succinate

30. Sedaplus

31. Smr000058436

32. Decapryn (tn)

33. Dsstox_cid_552

34. Doxylamine Succinate (usp)

35. Butanedioic Acid, Compd. With N,n-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1)

36. Dsstox_rid_75656

37. Ethanamine, N,n-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, Butanedioate (1:1)

38. Dsstox_gsid_20552

39. Butanedioic Acid, Compd. Withn,n-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)other Ca Index Names:ethanamine, N,n-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-,butanedioate (1:1)

40. N,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine Succinate

41. Topcare Sleep Aid

42. Butanedioic Acid, Compd. With N,n-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)

43. Ccris 4811

44. Sr-01000003036

45. Einecs 209-228-7

46. Equaline Sleep Aid

47. Mfcd00056168

48. Nsc 74772

49. Doxylamine Succinate Liquid

50. Unii-v9bi9b5yi2

51. Safetussin

52. Ai3-23993

53. Ncgc00017028-02

54. Cas-562-10-7

55. Prestwick_887

56. Dimethylaminoethoxy-methyl-benzyl-pyridine Succinate

57. Decamium

58. 2-dimethylaminoethoxyphenylmethyl-2-picoline Succinate

59. Opera_id_566

60. Phenyl2-pyridylmethyl-beta-n,n-dimethylaminoethyl Ether Succinate

61. 2-(alpha-(2-dimethylaminoethoxy)-alpha-methylbenzyl)pyridine Succinate

62. 2-(alpha(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine Succinate (1:1)

63. Alpha-(2-dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline Acid Succinate

64. Pyridine, Succinate (1:1)

65. Mls000758288

66. Mls001076141

67. Mls001424137

68. Mls002222274

69. Schembl160443

70. Spectrum1500267

71. Chembl1200392

72. Dtxsid7020552

73. Doxylamine For System Suitability

74. Hms502k03

75. Doxylamine Succinate [mi]

76. Hms1568e15

77. Hms1920k04

78. Hms2051f14

79. Hms2091b09

80. Hms2095e15

81. Hms2231g05

82. Hms3261e17

83. Hms3370k04

84. Hms3393f14

85. Hms3652h19

86. Hms3712e15

87. Hms3885d13

88. Pharmakon1600-01500267

89. Doxylamine Succinate [iarc]

90. Bcp24067

91. Hy-a0069

92. Nsc74772

93. Doxylamine Succinate [vandf]

94. Tox21_113515

95. Tox21_202078

96. Tox21_302861

97. Tox21_500348

98. Ccg-38929

99. Doxylamine Succinate [mart.]

100. Nsc756752

101. S4240

102. Doxylamine Succinate [usp-rs]

103. Doxylamine Succinate [who-dd]

104. Akos025310916

105. Butanedioic Acid,n,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine

106. Tox21_113515_1

107. Ac-4487

108. Ccg-101033

109. Cs-3232

110. Lp00348

111. Nc00283

112. Nsc-756752

113. Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, Succinate (1:1)

114. Doxylamine Succinate [green Book]

115. Ncgc00016140-02

116. Ncgc00016140-03

117. Ncgc00016140-04

118. Ncgc00021147-11

119. Ncgc00089789-03

120. Ncgc00093785-01

121. Ncgc00093785-02

122. Ncgc00093785-03

123. Ncgc00256517-01

124. Ncgc00259627-01

125. Ncgc00261033-01

126. As-13661

127. Doxylamine Succinate [orange Book]

128. Succinic Acid, Compd. With 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1)

129. Db-052868

130. Doxylamine Succinate [usp Monograph]

131. D5583

132. Eu-0100348

133. Ft-0625595

134. Ft-0667789

135. Sw197008-4

136. Wln: T6nj Bx1&r&o2n1&1 &ov2vo

137. Bonjesta Component Doxylamine Succinate

138. Diclegis Component Doxylamine Succinate

139. Bendectin Component Doxylamine Succinate

140. C19414

141. D 3775

142. D-9200

143. D02327

144. D81886

145. Diclectin Component Doxylamine Succinate

146. Doxylamine Succinate Component Of Bonjesta

147. Doxylamine Succinate Component Of Diclegis

148. Doxylamine Hydrogen Succinate [ep Impurity]

149. Doxylamine Succinate Component Of Bendectin

150. Doxylamine Hydrogen Succinate [ep Monograph]

151. Sr-01000003036-2

152. Sr-01000003036-6

153. Sr-01000003036-9

154. (dimethylamino)ethoxy-methyl-benzyl-pyridine Succinate

155. F2173-1155

156. [[[(2-dimethylamino)ethoxy]phenyl]methyl]-2-picoline Succinate

157. 2-[a-[2-(dimethylamino)ethoxy]-a-methylbenzyl]pyridine Succinate

158. Doxylamine Hydrogen Succinate 1.0 Mg/ml In Methanol (as Free Base)

159. Doxylamine Succinate, United States Pharmacopeia (usp) Reference Standard

160. N,n-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanaminesuccinate

161. Phenyl2-pyridylmethyl-(.beta.-n,n-dimethylamino)ethyl Ether Succinate

162. 2-(.alpha.(2-(dimethylamino)ethoxy)-.alpha.-methylbenzyl)pyridine Succinate (1:1)

163. 2-[[.alpha.-(2-dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine Succinate

164. Butanedioic Acid,n-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)

165. Doxylamine For System Suitability, European Pharmacopoeia (ep) Reference Standard

166. Doxylamine Hydrogen Succinate, European Pharmacopoeia (ep) Reference Standard

167. Doxylamine Succinate, Pharmaceutical Secondary Standard; Certified Reference Material

168. Doxylamine Succinate Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material

169. N,n-dimethyl-2-((1rs)-1-phenyl-1-(pyridin-2-yl)ethoxy(ethanamine Hydrogen Butanedioate

170. Succinic Acid, Compd. With 2-[.alpha.-[2-(dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine (1:1)

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 388.5 g/mol
Molecular Formula C21H28N2O5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count9
Exact Mass388.19982200 g/mol
Monoisotopic Mass388.19982200 g/mol
Topological Polar Surface Area100 Ų
Heavy Atom Count28
Formal Charge0
Complexity369
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameDoxylamine succinate
Drug LabelTAMPER EVIDENT: Do not use if printed foil inner seal under bottle cap is broken or missing. Failure to follow these warnings could result in serious consequences.www.sambrosadreams.comProcessed in the United States with Foreign IngredientsDist. by S...
Active IngredientDoxylamine succinate
Dosage FormTablet
RouteOral
Strength25mg
Market StatusOver the Counter
CompanyPerrigo; Lnk

2 of 4  
Drug NameUnisom
PubMed HealthDoxylamine (By mouth)
Drug ClassesRespiratory Agent
Active IngredientDoxylamine succinate
Dosage FormTablet
RouteOral
Strength25mg
Market StatusOver the Counter
CompanyChattem

3 of 4  
Drug NameDoxylamine succinate
Drug LabelTAMPER EVIDENT: Do not use if printed foil inner seal under bottle cap is broken or missing. Failure to follow these warnings could result in serious consequences.www.sambrosadreams.comProcessed in the United States with Foreign IngredientsDist. by S...
Active IngredientDoxylamine succinate
Dosage FormTablet
RouteOral
Strength25mg
Market StatusOver the Counter
CompanyPerrigo; Lnk

4 of 4  
Drug NameUnisom
PubMed HealthDoxylamine (By mouth)
Drug ClassesRespiratory Agent
Active IngredientDoxylamine succinate
Dosage FormTablet
RouteOral
Strength25mg
Market StatusOver the Counter
CompanyChattem

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Histamine H1 Antagonists

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Histamine Receptor Antagonists [MoA]; Antihistamine [EPC]

API SUPPLIERS

read-more
read-more

01

Bioxera Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBioXera Pharma: A trusted partner for high-quality human and veterinary APIs and intermediates across global regulated markets.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Bioxera CB

02

Pharm-RX Chemical

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Pharm RX

03

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

04

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rochem

05

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

06

Malladi Drugs & Pharmaceuticals Li...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMalladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Malladi

07

Tenatra Exports

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Tenatra

08

Harika Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHarika Drugs has been providing a qualitative range of Bulk Drugs/ APIs since 1993.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Harika Company Banner

09

Honour Lab Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
Company Banner

10

Sigma-Aldrich Corporation

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

RLD : No

TE Code :

DOXYLAMINE SUCCINATE

Brand Name : DECAPRYN

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Approval Date : 1982-01-01

Application Number : 6412

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

RLD : No

TE Code :

DOXYLAMINE SUCCINATE

Brand Name : DECAPRYN

Dosage Form : TABLET;ORAL

Dosage Strength : 12.5MG

Approval Date : 1982-01-01

Application Number : 6412

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

RLD : No

TE Code :

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Brand Name : BENDECTIN

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 10598

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Sanofi Company Banner

04

Pharma
Not Confirmed
arrow
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Brand Name : DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 20MG;20MG

Approval Date : 2022-03-01

Application Number : 212472

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

05

BIONPHARMA

U.S.A
Pharma
Not Confirmed
arrow

BIONPHARMA

U.S.A
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Brand Name : DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

Dosage Form : TABLET, DELAYED RELEASE;ORAL

Dosage Strength : 10MG;10MG

Approval Date : 2023-08-04

Application Number : 217000

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

CHATTEM

U.S.A
Pharma
Not Confirmed
arrow

CHATTEM

U.S.A
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE

Brand Name : UNISOM

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Approval Date : 1982-01-01

Application Number : 18066

RX/OTC/DISCN : OTC

RLD : Yes

TE Code :

blank

07

DUCHESNAY

Canada
Pharma
Not Confirmed
arrow

DUCHESNAY

Canada
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Brand Name : DICLEGIS

Dosage Form : TABLET, DELAYED RELEASE;ORAL

Dosage Strength : 10MG;10MG

Approval Date : 2013-04-08

Application Number : 21876

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

DUCHESNAY

Canada
Pharma
Not Confirmed
arrow

DUCHESNAY

Canada
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Brand Name : BONJESTA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 20MG;20MG

Approval Date : 2016-11-07

Application Number : 209661

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

PERRIGO

Ireland
Pharma
Not Confirmed
arrow

PERRIGO

Ireland
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE

Brand Name : DOXYLAMINE SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Approval Date : 1996-09-18

Application Number : 40167

RX/OTC/DISCN : OTC

RLD : No

TE Code :

blank

10

PFIZER

U.S.A
Pharma
Not Confirmed
arrow

PFIZER

U.S.A
arrow
Pharma
Not Confirmed

DOXYLAMINE SUCCINATE

Brand Name : UNISOM

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Approval Date : 1986-02-05

Application Number : 19440

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

API Stability Enhancers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Empty Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 562-10-7 / Doxylamine Succinate API manufacturers, exporters & distributors?

Doxylamine Succinate manufacturers, exporters & distributors 1

66

PharmaCompass offers a list of Doxylamine Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Doxylamine Succinate manufacturer or Doxylamine Succinate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxylamine Succinate manufacturer or Doxylamine Succinate supplier.

API | Excipient name

Doxylamine Succinate

Synonyms

562-10-7, Decapryn, Doxylamine (succinate), Gittalun, Unisom, Doxylamine hydrogen succinate

Cas Number

562-10-7

Unique Ingredient Identifier (UNII)

V9BI9B5YI2

About Doxylamine Succinate

Doxylamine Succinate is a pyridine derivate histamine H1 antagonist with pronounced sedative properties. Doxylamine succinate competitively blocks the histamine H1 receptor and limits the typical allergic and anaphylactic responses, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contraction of gastrointestinal smooth muscle, caused by actions of histamine on bronchial and gastrointestinal smooth muscles, and on capillaries. This drug also prevents histamine-induced pain and itching of the skin and mucous membranes.

Doxylamine succinate salt Manufacturers

A Doxylamine succinate salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxylamine succinate salt, including repackagers and relabelers. The FDA regulates Doxylamine succinate salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxylamine succinate salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Doxylamine succinate salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Doxylamine succinate salt Suppliers

A Doxylamine succinate salt supplier is an individual or a company that provides Doxylamine succinate salt active pharmaceutical ingredient (API) or Doxylamine succinate salt finished formulations upon request. The Doxylamine succinate salt suppliers may include Doxylamine succinate salt API manufacturers, exporters, distributors and traders.

click here to find a list of Doxylamine succinate salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Doxylamine succinate salt USDMF

A Doxylamine succinate salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxylamine succinate salt active pharmaceutical ingredient (API) in detail. Different forms of Doxylamine succinate salt DMFs exist exist since differing nations have different regulations, such as Doxylamine succinate salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Doxylamine succinate salt DMF submitted to regulatory agencies in the US is known as a USDMF. Doxylamine succinate salt USDMF includes data on Doxylamine succinate salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxylamine succinate salt USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Doxylamine succinate salt suppliers with USDMF on PharmaCompass.

Doxylamine succinate salt KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Doxylamine succinate salt Drug Master File in Korea (Doxylamine succinate salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxylamine succinate salt. The MFDS reviews the Doxylamine succinate salt KDMF as part of the drug registration process and uses the information provided in the Doxylamine succinate salt KDMF to evaluate the safety and efficacy of the drug.

After submitting a Doxylamine succinate salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxylamine succinate salt API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Doxylamine succinate salt suppliers with KDMF on PharmaCompass.

Doxylamine succinate salt CEP

A Doxylamine succinate salt CEP of the European Pharmacopoeia monograph is often referred to as a Doxylamine succinate salt Certificate of Suitability (COS). The purpose of a Doxylamine succinate salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Doxylamine succinate salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Doxylamine succinate salt to their clients by showing that a Doxylamine succinate salt CEP has been issued for it. The manufacturer submits a Doxylamine succinate salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Doxylamine succinate salt CEP holder for the record. Additionally, the data presented in the Doxylamine succinate salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Doxylamine succinate salt DMF.

A Doxylamine succinate salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Doxylamine succinate salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Doxylamine succinate salt suppliers with CEP (COS) on PharmaCompass.

Doxylamine succinate salt WC

A Doxylamine succinate salt written confirmation (Doxylamine succinate salt WC) is an official document issued by a regulatory agency to a Doxylamine succinate salt manufacturer, verifying that the manufacturing facility of a Doxylamine succinate salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxylamine succinate salt APIs or Doxylamine succinate salt finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxylamine succinate salt WC (written confirmation) as part of the regulatory process.

click here to find a list of Doxylamine succinate salt suppliers with Written Confirmation (WC) on PharmaCompass.

Doxylamine succinate salt NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxylamine succinate salt as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Doxylamine succinate salt API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Doxylamine succinate salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Doxylamine succinate salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxylamine succinate salt NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Doxylamine succinate salt suppliers with NDC on PharmaCompass.

Doxylamine succinate salt GMP

Doxylamine succinate salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Doxylamine succinate salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Doxylamine succinate salt GMP manufacturer or Doxylamine succinate salt GMP API supplier for your needs.

Doxylamine succinate salt CoA

A Doxylamine succinate salt CoA (Certificate of Analysis) is a formal document that attests to Doxylamine succinate salt's compliance with Doxylamine succinate salt specifications and serves as a tool for batch-level quality control.

Doxylamine succinate salt CoA mostly includes findings from lab analyses of a specific batch. For each Doxylamine succinate salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Doxylamine succinate salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxylamine succinate salt EP), Doxylamine succinate salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxylamine succinate salt USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty